Post by Gerresheimer

Non-adherence rates for chronic disease therapies are >50%. Standalone patient apps try to address this issue, but onboarding friction and app fatigue can stall adoption. Our Gx AdheraLink™ agentic AI-driven solution is different. It supports patients on their therapy journey via empathetic 2-way communication in an instant messaging app they’re already familiar with. 𝐀𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞𝐬 𝐨𝐟 𝐆𝐱 𝐀𝐝𝐡𝐞𝐫𝐚𝐋𝐢𝐧𝐤™ 𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 ✦ 𝐙𝐞𝐫𝐨-𝐟𝐫𝐢𝐜𝐭𝐢𝐨𝐧 𝐞𝐧𝐠𝐚𝐠𝐞𝐦𝐞𝐧𝐭: instant 24/7 responses, administration reminders, and guidance with no new app install, no set-up, and no learning curve ✦ 𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝, 𝐭𝐫𝐮𝐬𝐭𝐰𝐨𝐫𝐭𝐡𝐲 𝐚𝐝𝐯𝐢𝐜𝐞: a closed system of pharma-approved content ensures safe, instant, auditable advice ✦ 𝐀𝐝𝐚𝐩𝐭𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐬𝐜𝐚𝐥𝐚𝐛𝐥𝐞: leveraging global infrastructure and established technology means fast customization and scaling across geographies ✦ 𝐑𝐎𝐈 𝐟𝐨𝐫 𝐩𝐡𝐚𝐫𝐦𝐚: Break-even point can be reached with as little as 0.1 % uptake in adherence, plus you gain invaluable patient insights Learn more about the solution on our website: https://lnkd.in/eTYkvCPE   #DigitalHealth #PatientAdherence #PharmaInnovation #AIinHealthcare #MedTech #Gerresheimer #GxAdheraLink #ELeaflets #DrugPackaging #Gerresheimer #innovatingforabetterlife